ILC Dover

Flexible Powder Containment Technologies

Powder containment technology

ILC Dover offers flexible powder containment technologies, eliminating problems associated with the use of traditional metal and glass systems for the pharmaceutical industry.

The company applies flexible solutions to pharmaceutical potent powder containment during processing of bulk compounds and oral solid dosage manufacturing throughout the industry from North America to Europe and Asia.

As demonstrated by the Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP) principles, both current good manufacturing practices (cGMP) and industrial hygiene (IH) needs can be met by containing the process at the source. By employing flexible containment and using the logic diagrams from the Risk-MaPP process, cleaning is minimised and the operator is protected with this engineering control. As such, processes in multi-product facilities can be safely performed without the risk of cross contamination.

DoverPac® flexible containment technologies offer:

  • Protection from potent compounds
  • cGMP for active pharmaceutical ingredients (API) and bulk manufacturers
  • Low capital costs
  • Rapid turnkey solutions
  • No risk of cross contamination in multi-process and dedicated facilities
  • Lowest cost of processing

Containment services for bulk compound processing

DoverPac® has gained wide acceptance by the pharmaceutical industry for use during processing of bulk compounds. DoverPac® prevents worker exposure to highly potent compounds and can eliminate the need for protective garments and respirators.

The new EZ Biopac is a contaminant and transfer system designed for easy adjustment to different bulk weights. Achieving a precice and quick fill time, the system keeps the discharge outlet seperate from antistatic polymer material resulting in 2g or less residule in a 5kg bag. In addition, the EZ Biopac has a protective bag to help ensure the support stand and exterior are not contaminated.

Continuous contained powder processing

ILC Dover's flexible containment technologies allow continuous, contained processing utilizing ArmorFlex™ films developed specifically for the pharmaceutical industry. DoverPac® fabrication techniques are based on over 50 years of experience in life-critical product manufacturing.

Containment for potent compounds

Unlike standard flexible intermediate bulk containers that are not designed specifically for potent compound manufacturing, DoverPac® is designed to assist operators in performing operations without ever opening up the system. And, our ISO: 9001 registration assures product quality and operator safety during pharmaceutical potent powder containment operations.

FDA and EU compliant

ILC’s innovative ArmorFlex containment material is compliant with US Food and Drug Administration (FDA) and EU requirements:

  • Complies with FDA 21 CFR
  • Meets 2002 / 72 / EC requirements
  • Passes USP 661 physicochemical tests for plastics
  • Passes USP 88 class VI (7 day implant)

Validated processes

Flexible containment is a validated process that utilizes quality engineered products designed to meet critical requirements for:

  • Five year shelf-life
  • Permanent antistant replaces migrating additives
  • Passes chilworth incendivity tests
  • Drug master file (DMF) filed with FDA

Upgrade existing facilities for potent compound containment

DoverPac® is one of the fastest growing containment solutions in the industry. Our worldwide clients have appreciated the ability to upgrade existing facilities for potent compound containment during processing. This ability to upgrade has allowed our clients to avoid the capital expense of new equipment and / or facility upgrades. And, the fast turn around to facility upgrading for pharmaceutical containment has meant significant decreases in facility start-up times.

Contact Details

ILC Dover LP
One Moonwalker Road
DE 19946-2080
United States of America
+1 302 335 3911
+1 302 335 1320

Available White Papers


Rapid Mixing of Clumped Powder on Large-Scale Validated by Testing 22 August 2017 Mixing powders into liquids efficiently is crucial to productivity in pharmaceutical and biopharmaceutical manufacturing.


How to Boost Profits With Single-Use Powder Transfer 28 April 2017 Many biopharmaceutical manufacturers are implementing single-use containment and transfer of media and buffer materials to prevent feedstock contamination and promote worker safety.

Company Videos